Business · 16/11/1999
FDA Revokes Guidance Texts for Progestational Drug Products
The Food and Drug Administration (FDA) is revoking its previously issued guidance texts for physician and patient labeling for progestational drug products, as no comments were received on the notice announcing the revocation, published in the Federal Register on April 13, 1999.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →